Table 10.
Summary of the prevalence of BLV detection of investigated cases and controls.
| Study | BLV-Positive Cases/Total | BLV-Positive Controls/Total | Statistically Significant? Y/N (p-Value) |
|---|---|---|---|
| Olaya-Galán, 2021 [174] | 46/75 (61%) | 40/83 (48%) # | No (p = 0.1113) |
| Delarmelina, 2020 [175] | 47/49 (96%) 46/49 (94%) for the tax gene 28/49 (57%) for the env gene |
23/39 (59%) ^ 20/39 (51%) ^ for the tax gene 14/39 (36%) ^ for the env gene |
Yes (p < 0.001) |
| Schwingel, 2019 [176] | 22/72 (31%) | 10/72 (14%) ^ | Yes (p = 0.0265) |
| Baltzell, 2018 [36] | 35/61 (57%) | 20/103 (20%) § | Yes (p < 0.0001) |
| Buehring, 2017 [177] | 40/50 (80%) | 19/46 (41%) # | Yes (p = 0.0001) |
| Buehring, 2015 [180] | 67/114 (59%) | 30/104 (29%) ^ | Yes (p < 0.0001) |
# unspecified benign lesions, § normal breast tissue from the same patient, ^ normal breast tissue from healthy patients.